已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Delivery of RNAi Therapeutics: Building Multifunctional RNAi Triggers for Extra-Hepatic Targeting and Endosomal Escape

作者
Aaron D. Springer
出处
期刊:California Digital Library - eScholarship [California Digital Library]
摘要

The discovery of RNAi and the subsequent demonstration that synthetic short interfering RNA (siRNA) could silence all mRNA expression in a sequence dependent manner offered tremendous potential as a therapeutic to treat all genetic disease. However, siRNA is both too large (>14,000 Da) and too charged (40+ phosphates) to passively diffuse across the cell membrane, requiring a targeting domain to deliver the siRNA therapeutic. Conjugation of siRNA to tris-N-acetylgalactosamine (GalNAc) targeting liver asialoglycoprotein receptor (ASGPR) revolutionized RNAi therapeutics and the problem of hepatic delivery can now be considered solved. However, siRNA therapeutics have not seen the same success in extra-hepatic tissues as the biology of these tissues has proven more difficult for siRNA targeting and delivery.\tTo address the issue of siRNA delivery, our laboratory developed short interfering ribonucleic neutrals (siRNN) whose charged phosphodiester backbone has been neutralized by bioreversible phosphotriester groups. The first generation siRNN utilized a t-butyl-s-acyl-2-thioethyl (tBu-SATE) phosphotriester group that allowed enhanced in vivo GalNAc-siRNA delivery. To adapt this technology for extra-hepatic delivery, we modified the tBu-SATE phosphotriester to allow site-specific conjugation through copper catalyzed Click chemistry. Conjugation of mannose to siRNNs effectively delivered siRNN to CD206+ macrophages and elicited a robust RNAi response in a model of tumor-associated macrophages (TAMs). Unfortunately, additional ligand/receptor pairs like mannose/CD206 and GalNAc/ASGPR that are tissue specific, highly expressed, and rapidly internalize are extremely limited. An alternative to small ligands is the use of antibodies. Traditional antibody targeted therapies often rely on conjugations that result in a poorly defined, heterogeneous mixtures of antibody-drug conjugates. To conjugate siRNNs to antibodies in a quantitative manner, we developed a site-specific enzymatic conjugation strategy. Unfortunately, the resulting antibody RNA conjugates (ARC) failed to deliver the siRNN into the cytoplasm, likely due to endosomal entrapment. To avoid entrapment, endosomal escape domains (EED) were incorporated into the ARC through a hydrazone conjugation phosphotriester to form an ARC-EED. Taken together, this work describes the development of novel, well defined, site-specific, multifunctional, and multivalent siRNN conjugates capable of extra-hepatic targeting and endosomal escape.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
我是老大的应助被刻苦乐天采纳,获得10
2秒前
2秒前
忧郁芷烟发布了新的文献求助10
3秒前
FashionBoy的应助被隐形的晓灵采纳,获得10
3秒前
4秒前
华仔的应助被狗熊岭在逃翠花采纳,获得10
4秒前
冷酷惠完成签到 ,获得积分10
4秒前
4秒前
小二郎的应助被三花大户采纳,获得10
7秒前
余叶发布了新的文献求助10
7秒前
科学心完成签到,获得积分10
8秒前
isabella完成签到,获得积分10
8秒前
8秒前
任性雁露发布了新的文献求助10
9秒前
9秒前
不易发布了新的文献求助10
9秒前
下北沢之兽完成签到 ,获得积分10
11秒前
CipherSage的应助被DW采纳,获得10
11秒前
李健完成签到,获得积分10
13秒前
hsj完成签到,获得积分10
14秒前
15秒前
15秒前
15秒前
Hunter完成签到,获得积分10
16秒前
16秒前
17秒前
三花大户发布了新的文献求助10
19秒前
K2C完成签到,获得积分10
20秒前
正直雪柳完成签到,获得积分20
20秒前
刻苦乐天发布了新的文献求助10
21秒前
姜OMG发布了新的文献求助10
21秒前
光亮的成败完成签到,获得积分10
21秒前
紫菜珍藏版完成签到 ,获得积分10
22秒前
科研通AI65的应助被DW采纳,获得10
23秒前
26秒前
姜OMG完成签到,获得积分10
27秒前
妖九笙完成签到 ,获得积分10
27秒前
imcwj完成签到 ,获得积分10
29秒前
小徐完成签到 ,获得积分10
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184889
求助须知:如何正确求助?哪些是违规求助? 9573836
关于积分的说明 21833242
捐赠科研通 7782263
什么是DOI,文献DOI怎么找? 3434429
关于科研通互助平台的介绍 2558581
邀请新用户注册赠送积分活动 2481082